Search research articles
Contact Us
Filters
Showing results (331-340 of 338) with videos related to
Page
of 34
Sort By:
You have reached the last page of results.
This site can display upto 338 results.
Leukemia
|
October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response
Meagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Cancer Discovery
|
August 23, 2020
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia
Melissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, et al.
JCO Precision Oncology
|
May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia
Erica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
The New England Journal of Medicine
|
March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers
Eric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
The New England Journal of Medicine
|
September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic Syndrome
Eric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Antimicrobial Agents and Chemotherapy
|
November 13, 2019
A Standard Numbering Scheme for Class C β-Lactamases
Andrew R Mack, Melissa D Barnes, Magdalena A Taracila, et al.
The New England Journal of Medicine
|
December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S Welch, Allegra A Petti, Christopher A Miller, et al.
Blood
|
November 18, 2022
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, et al.
Page
of 34
Search research articles
Search
Showing results (331-340 of 338) with videos related to
Sort By:
Page
of 34
You have reached the last page of results.
This site can display upto 338 results.
Leukemia
|
October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response
Meagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Cancer Discovery
|
August 23, 2020
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia
Melissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, et al.
JCO Precision Oncology
|
May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia
Erica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
The New England Journal of Medicine
|
March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers
Eric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
The New England Journal of Medicine
|
September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic Syndrome
Eric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Antimicrobial Agents and Chemotherapy
|
November 13, 2019
A Standard Numbering Scheme for Class C β-Lactamases
Andrew R Mack, Melissa D Barnes, Magdalena A Taracila, et al.
The New England Journal of Medicine
|
December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S Welch, Allegra A Petti, Christopher A Miller, et al.
Blood
|
November 18, 2022
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, et al.
Page
of 34